AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2009
Nov 16, 2009
35599_dirs_2009-11-16_2306f7de-cfe8-41f2-ae55-6d3bcf57521c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ADHEREX TECHNOLOGIES INC (ADHXF)
CIK: 0001211583
Period of Report: 2009-11-16
Reporting Person: NORRIS ROBIN J (President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-11-16 | Stock Options (Right to Buy) | $0.06 | A | 200000 | Acquired | 2016-11-16 | Common Stock (200000) | Direct |
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20